Cart
sales@molnova.com
Calcium Channel antagonist 4
CAS No. 687574-49-8
Calcium Channel antagonist 4( —— )
Catalog No. M37074 CAS No. 687574-49-8
Calcium Channel antagonist 4 is a voltage-gated calcium channel inhibitor (IC50 : 5-20 μM).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 10MG | 37 | In Stock |
|
| 25MG | 57 | In Stock |
|
| 50MG | 84 | In Stock |
|
| 100MG | 120 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameCalcium Channel antagonist 4
-
NoteResearch use only, not for human use.
-
Brief DescriptionCalcium Channel antagonist 4 is a voltage-gated calcium channel inhibitor (IC50 : 5-20 μM).
-
DescriptionCalcium Channel antagonist 4 (compound 189) is an inhibitor of voltage-gated calcium channels with an IC50 value of 5-20μM.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayGPCR/G Protein
-
TargetCalcium Channel
-
RecptorCalcium Channel
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number687574-49-8
-
Formula Weight426.53
-
Molecular FormulaC23H26N2O4S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCC=1C=2C(OC1C(NCC3=CC=CC=C3)=O)=CC=C(S(=O)(=O)N4CCC(C)CC4)C2
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Termin, Andreas P, et, al. Benzofuran, indole and benzothiophene sulfonamide calcium channel antagonists for treating pain. WO2006010008 A1 2006-01-26.
molnova catalog
related products
-
O-1602
O-1602 is a novel GPR55 agonist, an atypical cannabinoid associated with the central nervous system and obesity, and is a candidate compound for the treatment of cystitis.
-
Ziconotide Acetate ...
Ziconotide is an analgesic agent and has been used to treat neuropathic and non-neuropathic pain. Ziconotide acts by binding to N-type calcium channels situated on the terminal part of primary afferent neurons of the nociceptive pathway therefore reducing synaptic transmission with potent antinociceptive effects.
-
CBD3063
CBD3063 is a CRMP2-based peptidomimetic small molecule with analgesic and neuroprotective effects, which can allosterically regulate Cav 2.2 and can be used to study neurological diseases.
